{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T06:05:42Z","timestamp":1789020342623,"version":"build-2803163510"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,11,6]],"date-time":"2015-11-06T00:00:00Z","timestamp":1446768000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drug Deliv. and Transl. Res."],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1007\/s13346-015-0262-y","type":"journal-article","created":{"date-parts":[[2015,11,6]],"date-time":"2015-11-06T18:39:34Z","timestamp":1446835174000},"page":"48-56","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":38,"title":["Formulation and comparative evaluation of HPMC and water soluble chitosan-based sparfloxacin nanosuspension for ophthalmic delivery"],"prefix":"10.1007","volume":"6","author":[{"given":"Nitin Prabhakar","family":"Ambhore","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panchaxari Mallapa","family":"Dandagi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anand Panchakshari","family":"Gadad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,11,6]]},"reference":[{"key":"262_CR1","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1001\/jama.2013.280318","volume":"310","author":"AA Azari","year":"2013","unstructured":"Azari AA, Barney NP. Conjunctivitis: a systematic review of diagnosis and treatment. JAMA. 2013;310:1721\u201329.","journal-title":"JAMA"},{"issue":"2","key":"262_CR2","doi-asserted-by":"crossref","first-page":"162","DOI":"10.4103\/0975-7406.111824","volume":"5","author":"H Gupta","year":"2013","unstructured":"Gupta H, Aqil M, Khar RK, Ali A, Bhatnagar A. Nanoparticles laden in situ gel for sustained ocular drug delivery. J Pharm Bioall Sci. 2013;5(2):162\u20135.","journal-title":"J Pharm Bioall Sci"},{"key":"262_CR3","doi-asserted-by":"crossref","first-page":"191","DOI":"10.2332\/allergolint.11-RAI-0335","volume":"60","author":"E Takamura","year":"2011","unstructured":"Takamura E, Uchio E, Ebihara N, Ohno S, Ohashi Y, Okamoto S, et al. Japanese guideline for allergic conjunctival diseases. Allergol Int. 2011;60:191\u2013203.","journal-title":"Allergol Int"},{"key":"262_CR4","doi-asserted-by":"crossref","unstructured":"Khimdas S, Visscher KL, Hutnik CML. Besifloxacin ophthalmic suspension\u202f: emerging evidence of its therapeutic value in bacterial conjunctivitis. Ophthalmol Eye Dis 2011; 37\u201342.","DOI":"10.4137\/OED.S4102"},{"key":"262_CR5","unstructured":"O\u2019Brien TP, Thanathanee O Refining treatment of bacterial conjunctivitis. Ophthalmol Manag 2011; 4 [Online] http:\/\/www.ophthalmologymanagement.com\/printarticle.aspx?articleID=105514 ."},{"issue":"1","key":"262_CR6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.9734\/OR\/2013\/2442","volume":"1","author":"AE Gawad","year":"2013","unstructured":"Gawad AE, Gawad HAE, Soliman OA, Barker SA, Girgis GNS. Formulation and physical characterization of a novel sustained-release ophthalmic delivery system for sparfloxacin\u202f: the effect of the biological environment. Ophthalmol Res Int J. 2013;1(1):1\u201322.","journal-title":"Ophthalmol Res Int J"},{"issue":"7","key":"262_CR7","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1211\/0022357023691","volume":"56","author":"VB Patravale","year":"2004","unstructured":"Patravale VB, Date AA, Kulkarni RM. Nanosuspensions: a promising drug delivery strategy. J Pharm Pharmacol. 2004;56(7):827\u201340.","journal-title":"J Pharm Pharmacol"},{"issue":"2","key":"262_CR8","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.nano.2010.07.003","volume":"7","author":"S Das","year":"2011","unstructured":"Das S, Suresh PK. Nanosuspension : a new vehicle for the improvement of the delivery of drugs to the ocular surface. Application to amphotericin B. Nanomed Nanotechnol Biol Med. 2011;7(2):242\u201347.","journal-title":"Nanomed Nanotechnol Biol Med"},{"issue":"3","key":"262_CR9","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.jconrel.2012.03.013","volume":"160","author":"L Gao","year":"2012","unstructured":"Gao L, Liu G, Ma J, Wang X, Zhou L, Li X. Drug nanocrystals : in vivo performances. J Control Release. 2012;160(3):418\u201330.","journal-title":"J Control Release"},{"issue":"3","key":"262_CR10","first-page":"16","volume":"40","author":"JS Reddy","year":"2013","unstructured":"Reddy JS, Ahmed MG. Sustained ocular delivery of sparfloxacin from pH triggered in situ gelling system. MU J Pharm. 2013;40(3):16\u201325.","journal-title":"MU J Pharm"},{"issue":"5","key":"262_CR11","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/j.ejps.2012.09.015","volume":"47","author":"M Talekar","year":"2012","unstructured":"Talekar M, Kendall J, Denny W, Jamieson S, Garg S. European journal of pharmaceutical sciences development and evaluation of PIK75 nanosuspension, a phosphatidylinositol-3-kinase inhibitor. Eur J Pharm Sci. 2012;47(5):824\u201333.","journal-title":"Eur J Pharm Sci"},{"issue":"6","key":"262_CR12","first-page":"304","volume":"9","author":"P Khadka","year":"2014","unstructured":"Khadka P, Ro J, Kim H, Lee H. Pharmaceutical particle technologies: an approach to improve drug solubility, dissolution and bioavailability. AJPS. 2014;9(6):304\u201316.","journal-title":"AJPS"},{"key":"262_CR13","doi-asserted-by":"crossref","unstructured":"Liu L, Lu Y. Liposomes containing bile salts as novel ocular delivery systems for tacrolimus (FK506): in vitro characterization and improved corneal permeation. Int J Nanomedicine. 2013: 1921\u20131933.","DOI":"10.2147\/IJN.S44487"},{"key":"262_CR14","doi-asserted-by":"crossref","first-page":"3031","DOI":"10.1016\/j.biomaterials.2005.12.021","volume":"27","author":"D Kim","year":"2006","unstructured":"Kim D, Martin DC. Sustained release of dexamethasone from hydrophilic matrices using PLGA nanoparticles for neural drug delivery. Biomaterials. 2006;27:3031\u20137.","journal-title":"Biomaterials"},{"key":"262_CR15","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.carbpol.2006.01.031","volume":"65","author":"L Fan","year":"2006","unstructured":"Fan L, Du Y, Zhang B, Yang J. Preparation and properties of alginate\/carboxymethyl chitosan blend fibers. Carbohydr Polym. 2006;65:447\u201352.","journal-title":"Carbohydr Polym"},{"issue":"4","key":"262_CR16","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.carbpol.2009.05.028","volume":"78","author":"A Anitha","year":"2009","unstructured":"Anitha A, Rani VVD, Krishna R, Sreeja V, Selvamurugan N, Nair SV. Synthesis, characterization, cytotoxicity and antibacterial studies of chitosan, O -carboxymethyl and N, O -carboxymethyl chitosan nanoparticles. Carbohydr Polym. 2009;78(4):672\u201377.","journal-title":"Carbohydr Polym"},{"issue":"3","key":"262_CR17","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1016\/j.jconrel.2013.08.006","volume":"172","author":"Y Wang","year":"2013","unstructured":"Wang Y, Zheng Y, Zhang L, Wang Q, Zhang D. Stability of nanosuspensions in drug delivery. J Control Release. 2013;172(3):1126\u201341.","journal-title":"J Control Release"},{"key":"262_CR18","first-page":"79","volume":"8","author":"P Dandagi","year":"2009","unstructured":"Dandagi P, Kerur S, Mastiholimath V. Polymeric ocular nanosuspension for controlled release of acyclovir : in vitro release and ocular distribution. IJPR. 2009;8:79\u201386.","journal-title":"IJPR"},{"issue":"1","key":"262_CR19","doi-asserted-by":"crossref","first-page":"11","DOI":"10.5185\/amlett.2010.3108","volume":"1","author":"VK Mourya","year":"2010","unstructured":"Mourya VK, Inamdar NN, Tiwari A. Carboxymethyl chitosan and its applications. Adv Mat Lett. 2010;1(1):11\u201333.","journal-title":"Adv Mat Lett"},{"issue":"1","key":"262_CR20","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.carbpol.2012.07.076","volume":"91","author":"L Upadhyaya","year":"2013","unstructured":"Upadhyaya L, Singh J, Agarwal V, Prakash R. Biomedical applications of carboxymethyl chitosans. Carbohydr Polym. 2013;91(1):452\u201366.","journal-title":"Carbohydr Polym"},{"key":"262_CR21","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.jconrel.2010.10.007","volume":"149","author":"HSM Ali","year":"2011","unstructured":"Ali HSM, York P, Ali MA, Blagden N. Hydrocortisone nanosuspensions for ophthalmic delivery: a comparative study between microfluidic nanoprecipitation and wet milling. J Control Release. 2011;149:175\u201381.","journal-title":"J Control Release"},{"key":"262_CR22","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.colsurfb.2013.02.043","volume":"108","author":"PP Ige","year":"2013","unstructured":"Ige PP, Baria RK, Gattani SG. Fabrication of fenofibrate nanocrystals by probe sonication method for enhancement of dissolution rate and oral bioavailability. Collo Surf Biointer. 2013;108:366\u201373.","journal-title":"Collo Surf Biointer"},{"key":"262_CR23","doi-asserted-by":"crossref","unstructured":"Shinde U, Ahmed MH, Singh K. Development of dorzolamide loaded 6-O -carboxymethyl chitosan nanoparticles for open angle glaucoma. JDD 2013:1\u201315.","DOI":"10.1155\/2013\/562727"},{"key":"262_CR24","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.carbpol.2013.01.054","volume":"94","author":"N Dilbaghi","year":"2013","unstructured":"Dilbaghi N, Kaur H, Ahuja M, Kumar S. Evaluation of tropicamide-loaded tamarind seed xyloglucan nanoaggregates for ophthalmic delivery. Carbohydr Polym. 2013;94:286\u201391.","journal-title":"Carbohydr Polym"},{"issue":"2","key":"262_CR25","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.nano.2009.10.004","volume":"6","author":"H Gupta","year":"2010","unstructured":"Gupta H, Aqil M, Khar RK, Ali A, Bhatnagar A, Mittal G. Sparfloxacin-loaded PLGA nanoparticles for sustained ocular drug delivery. Nanomedicine. 2010;6(2):324\u201333.","journal-title":"Nanomedicine"},{"key":"262_CR26","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.addr.2011.02.001","volume":"63","author":"L Wu","year":"2011","unstructured":"Wu L, Zhang J, Watanable W. Physical and chemical stability of drug nanoparticles. Adv Drug Deliv Rev. 2011;63:456\u201369.","journal-title":"Adv Drug Deliv Rev"},{"key":"262_CR27","doi-asserted-by":"crossref","first-page":"58","DOI":"10.17511\/ijpr.2014.i02.04","volume":"3","author":"CJ Patel","year":"2014","unstructured":"Patel CJ, Patel JV. Formulation and evaluation of chitosan nanoparticles containing glibenclamide. IJPRS. 2014;3:58\u201368.","journal-title":"IJPRS"},{"key":"262_CR28","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.ejps.2009.04.008","volume":"37","author":"RK Subedi","year":"2009","unstructured":"Subedi RK, Kang KW, Choi HK. Preparation and characterization of solid lipid nanoparticles loaded with doxorubicin. Eur J Pharm Sci. 2009;37:508\u201313.","journal-title":"Eur J Pharm Sci"},{"key":"262_CR29","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.ejpb.2008.05.008","volume":"70","author":"JY Fang","year":"2008","unstructured":"Fang JY, Fang CL, Liu CH, Su YH. Lipid nanoparticles as vehicles for topical psoralen delivery: solid lipid nanoparticles (SLN) versus nanostructured lipid carriers (NLC). Eur J Pharm Biopharm. 2008;70:633\u201340.","journal-title":"Eur J Pharm Biopharm"},{"key":"262_CR30","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/j.ejpb.2014.08.016","volume":"88","author":"M Kongsong","year":"2014","unstructured":"Kongsong M, Songsurang K, Sangvanich P, Siralertmukul K. Design, synthesis, fabrication and in vitro evalution of mucoadhesive 5-amino-2-mercaptobenzimidazole chitosan as low water soluble drug carriers. Eur J Pharm Biopharm. 2014;88:986\u201397.","journal-title":"Eur J Pharm Biopharm"},{"key":"262_CR31","doi-asserted-by":"crossref","unstructured":"Sutradhar KB, Khatun S, Luna IP. Increasing possibilities of nanosuspension. JNT 2013; http:\/\/dx.doi.org\/10.1155\/2013\/346581 .","DOI":"10.1155\/2013\/346581"}],"container-title":["Drug Delivery and Translational Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13346-015-0262-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13346-015-0262-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13346-015-0262-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,11]],"date-time":"2020-09-11T02:38:55Z","timestamp":1599791935000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13346-015-0262-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11,6]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,2]]}},"alternative-id":["262"],"URL":"https:\/\/doi.org\/10.1007\/s13346-015-0262-y","relation":{},"ISSN":["2190-393X","2190-3948"],"issn-type":[{"value":"2190-393X","type":"print"},{"value":"2190-3948","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,11,6]]}}}